Trial intelligence / Profile preview

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis

NCT00108849Phase 3Completed

Sponsor
Novo Nordisk
Start
Mar 2005
Primary completion
May 2007
Modality
Hormone, Biologic
Countries
2
01

Overview

A Phase 3 trial of estradiol in atrophic vaginitis, sponsored by Novo Nordisk. Started Mar 2005; status: completed.

02

Drugs

estradiol
03

Conditions

atrophic vaginitis

Beyond the preview

Go deeper on NCT00108849.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00108849.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call